Click below to explore OSSIO press releases and recent news articles written about OSSIOfiber® Intelligent Bone Regeneration Technology.
OSSIO in the Media
Great Day Houston: Dr. Robert Moore & Patient
Inside SoCal: Dr. Baravarian & Patient
Sonoran Living: Dr. Eugene De La Cruz & Patient
February 7, 2023
OSSIO Launches World’s First and Only Non-Permanent Compression Staple
October 17, 2022
OSSIO Closes Series C Financing of $38.5 Million
Proceeds will be used to strengthen awareness for the patient benefits of bio-integrative OSSIOfiber® implants and accelerate new product platforms into the major orthopedic fixation markets.
March 22, 2022
OSSIO Receives Vizient Contract for Bio-Integrative Orthopedic Fixation Technology
OSSIO, Inc., an orthopedic fixation company dedicated to improving orthopedic outcomes and experiences, receives Vizient contract for bio-integrative orthopedic technology.
In the News
October 17, 2022
Ossio closes $38.5M Series C
January 22, 2019
Becker’s Spine Review
A new class of bio-integrative implants’: Dr. Stuart Miller on orthobiologics and implant selection.
January 16, 2019
Orthopedics This Week
FDA clears Ossio’s Bio-Integrative Bone Fixation Implant
Interested in OSSIOfiber®?
Complete the form and an OSSIOfiber® Advisor will get in touch.
300 TradeCenter, Suite 3690
Woburn, MA, 01801
Science & Manufacturing Center
8 HaTochen Street
Cesarea, Israel 3079861
1. Data on file at OSSIO 2. Clinical study data on file at OSSIO 3. Kaiser, P.B., Watkins, I., Riedel, M. D., Cronin, P., Briceno, J., Kron, J. Y. (2019). Implant Removal Matrix for the Foot and Ankle Orthopaedic Surgeon. Foot & Ankle Specialist, 12(1), 79-97. https://doi.org/10.1177/1938640018791015 4. Pre-clinical animal studies (in-bone implantation of OSSIOfiber® and PLDLA control in rabbit femurs). Data on File at OSSIO.